Provides life insurance products in the United States. Issues fixed index annuities, linking returns to market indices with principal protection. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
This is an established company with proven profits.
Average growth of 13% a year over the last 4 years. Every year shown ended in profit.
The market pays 28.8× for every dollar of annual profit — around what a business like this usually costs.
Analysts' average target sits 16% below today's price.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Cost Efficiency: As sales grow, profit fails to keep the same pace.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 4 years, sales grew about 13% a year on average.
Over the last 12 months, executives reported 67 sells against just 9 buys. Not an alarm bell by itself, but a number worth watching.
The stock trades 16% above the average analyst price target.
We don’t have a report card for this stock yet — the data isn’t mature enough to grade. No grade is information too: it means the evidence is thin.
One-line summary: few numbers, an untested story. Keep watching.